Page last updated: 2024-09-03

toosendanin and Pancreatic Neoplasms

toosendanin has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, W; Pei, Z; Wang, G	1

Other Studies

1 other study(ies) available for toosendanin and Pancreatic Neoplasms

Article	Year
A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling. Biochemical and biophysical research communications, 2017, 11-04, Volume: 493, Issue:1 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Oncogene Protein v-akt; Pancreatic Neoplasms; Plant Extracts; TOR Serine-Threonine Kinases	2017

Article

Year

A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling.

Biochemical and biophysical research communications, 2017, 11-04, Volume: 493, Issue:1

Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Oncogene Protein v-akt; Pancreatic Neoplasms; Plant Extracts; TOR Serine-Threonine Kinases

2017